IQS-019
IQS-019 is a B cell receptor (BCR) kinase inhibitor. IQS-019 can inhibit the de-phosphorylation of constitutive and IgM-activated Syk, Lyn, and Btk. IQS-019 can inhibit cell proliferation, migration and induce apoptosis. IQS-019 exhibits antitumor activity and can be used for the research of cancer, such as B cell lymphoma[1].
Product Specifications
CAS Number
1630804-24-8
UNSPSC
12352005
Target
Apoptosis; Btk; Syk
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C1C(C2=C(Cl)C=CC=C2Cl)=CC3=C(N)N=C(NC4=CC=C(N5CCN(C)CC5)C=C4)N=C3N1C
Molecular Formula
C25H25Cl2N7O
Molecular Weight
510.42
References & Citations
[1]Balsas P, et al. Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. J Hematol Oncol. 2017 Mar 31;10 (1) :80.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![DNA-PKcs/PRKDC Mouse Monoclonal Antibody [2-B3]](https://cdn.genprice.uk/products/992/68dd1c8d061270361ea82071/imageurl/m1204-6.webp)
